Montreal, Canada · Founded 2021 · Acquired/Merged (Operating Subsidiary)
Operator of a biopharmaceutical company intended for pulmonary hypertension and musculoskeletal disorders. 35Pharma is based in Montreal, Canada and was founded in 2021. Its last known valuation is $950 million (Apr 2026). It has raised $70 million.
Last price · $/share
—
Implied valuation
$950.0M
Total raised
$70.0M
Last round
—
Team — not yet on record
No current team members for 35Pharma are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of 35Pharma with a free account
·Watch 35Pharma: the Monday email on marks, rounds and moves
